Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -23.81% is 56% above its 5-year average of -53.89%, near the high end of its 5-year range (-101.70%–-23.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 56.60% above its 12-month average of -54.86%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -23.81%.
RETURN ON INVESTED CAPITAL (ROIC)
-23.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-54.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-56.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-53.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.60%
CURRENT VS 3Y AVG
+57.78%
CURRENT VS 5Y AVG
+55.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
+31.52%
vs the sector median at left
Definium Therapeutics, Inc.
Market Cap
$4.66B
Return on Invested Capital (ROIC)
-23.81%
TTM Avg
-54.86%
3Y Avg
-56.39%
5Y Avg
-53.89%
Market Cap
$4.66B
Return on Invested Capital (ROIC)
9.68%
TTM Avg
9.25%
3Y Avg
8.40%
5Y Avg
7.66%
Market Cap
$4.67B
Return on Invested Capital (ROIC)
3.03%
TTM Avg
-0.36%
3Y Avg
-5.28%
5Y Avg
-5.99%
Market Cap
$4.62B
Return on Invested Capital (ROIC)
6.39%
TTM Avg
-7.12%
3Y Avg
-17.71%
5Y Avg
-17.71%
Market Cap
$4.71B
Return on Invested Capital (ROIC)
-18.48%
TTM Avg
-32.11%
3Y Avg
-33.07%
5Y Avg
-32.00%
Market Cap
$4.82B
Return on Invested Capital (ROIC)
-13.88%
TTM Avg
-24.38%
3Y Avg
-22.93%
5Y Avg
-25.00%
Market Cap
$4.85B
Return on Invested Capital (ROIC)
-13.09%
TTM Avg
-9.79%
3Y Avg
-21.15%
5Y Avg
-33.38%
Market Cap
$4.43B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$4.41B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-24.96%
3Y Avg
-29.08%
5Y Avg
-26.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.66B | -23.81% | -54.86% | -56.39% | -53.89% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 9.68% | 9.25% | 8.40% | 7.66% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.67B | 3.03% | -0.36% | -5.28% | -5.99% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 6.39% | -7.12% | -17.71% | -17.71% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | -18.48% | -32.11% | -33.07% | -32.00% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.82B | -13.88% | -24.38% | -22.93% | -25.00% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.85B | -13.09% | -9.79% | -21.15% | -33.38% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | -23.69% | -46.07% | -46.68% | -46.68% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.41B | -6.67% | -24.96% | -29.08% | -26.21% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | N/A | 37.59% | 8.11% | 6.10% |
ROIC
-23.8%
ROE
-38.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -23.81% |
| 2026-03-31 | -60.39% |
| 2025-12-31 | -44.54% |
| 2025-09-30 | -88.16% |
| 2025-06-30 | -57.37% |
| 2025-03-31 | -46.51% |
| 2024-12-31 | -39.47% |
| 2024-09-30 | -32.69% |
| 2024-06-30 | -39.98% |
| 2024-03-31 | -45.28% |
| 2023-12-31 | -101.70% |
| 2023-09-30 | -77.50% |
| 2023-06-30 | -75.66% |
| 2023-03-31 | -52.26% |
| 2022-12-31 | -43.61% |
| 2022-09-30 | -45.19% |
| 2022-06-30 | -55.56% |
| 2022-03-31 | -71.04% |
| 2021-12-31 | -61.10% |
| 2021-09-30 | -63.27% |
| 2021-06-30 | -54.37% |
| 2021-03-31 | -31.00% |
| 2020-12-31 | -64.50% |
| 2019-05-31 | -18.95% |
| 2019-02-28 | -26.95% |
| 2018-11-30 | -31.26% |
| 2018-08-31 | -31.32% |
| 2018-05-31 | -34.04% |
| 2018-02-28 | -30.00% |
| 2017-11-30 | -29.51% |
| 2017-08-31 | -32.60% |
